← FDA Drug Approvals (Drugs@FDA)

CYTARABINE

NDA · New Drug Application · Sponsor: TEVA PARENTERAL · Approved 1969-06-17

Drug application

FDA Application #

NDA016793

Application type

New Drug Application

Brand name

CYTARABINE

Generic name

Cytarabine

Active ingredients

CYTARABINE

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Discontinued

Sponsor

TEVA PARENTERAL

First approval

1969-06-17

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown